Two weeks after Trump bought Axon stock, ICE launched a $220 million taser procurement plan.

```

Two weeks before the launch of a federal procurement that could significantly boost Axon Enterprise’s valuation, Trump bought up to $5 million worth of the company’s stock, raising concerns among ethics experts and law enforcement policy insiders about a potential conflict of interest.

According to federal financial disclosure documents submitted by Trump in May this year, he purchased $1 million to $5 million worth of Axon stock on February 10. Two weeks later, on February 24, U.S. Immigration and Customs Enforcement (ICE) issued a procurement notice seeking about 17,800 new electroshock weapons and related ammunition/training, a five-year contract worth about $220 million in total.

CNBC reported that three procurement reviewers and law enforcement experts said the technical specifications of the contract in fact closely match Axon’s products. The White House denied any conflict of interest, stating the president’s assets are held in a trust managed by his children, and investment decisions are made by an independent third party. There is currently no evidence that Trump was involved in or aware of the procurement process.

Market-wise, Axon’s stock rose more than 34% cumulatively within a week after ICE posted the procurement notice, and surged more than 22% within a month after Trump’s purchase. As of the June 26 close, the stock was up about 7% from the purchase date; calculated on the upper limit of the disclosed interval, Trump’s paper gain is roughly $350,000.

Procurement specs point to Axon, contract not yet finalized

ICE’s procurement notice does not mention Axon by name, but its technical requirements are highly specific.

The notice calls for upgrades to Axon’s “Taser 10” model to replace ICE’s current X26P/X2 electroshock weapons—both Axon products. Specs include a 45-foot range and 10 independent targeting probes; procurement experts say these parameters in effect rule out other bidders.

According to investment firm Brown Advisory, Axon holds about 90% of the U.S. electroshock weapon market. If the contract is finalized, ICE’s stockpile would expand over fourfold, from roughly 4,300 units to more than 17,800.

However, the contract has not yet been awarded. Progress stalled due to price scale and leadership changes at the Department of Homeland Security (DHS). ICE issued the notice about a week before then-DHS Secretary Kristi Noem was dismissed; Noem herself had not approved the spending.

Noem had required DHS expenditures over $100,000 to be personally approved by the secretary’s office, but current Secretary Markwayne Mullin rescinded that regulation in April. DHS expects to move forward with the contract.

White House denies conflict of interest, ethics experts remain cautious

White House spokesperson Anna Kelly told CNBC, “There is no conflict of interest,” dismissing concerns as “an outdated narrative pushed by Democrats.” Under federal law, the president is exempt from the criminal conflict of interest statutes that apply to most executive branch officials.

Nonetheless, ethics experts and policy insiders remain cautious. Jordan Libowitz, vice president of communications at Citizens for Responsibility & Ethics in Washington (CREW), said:

“The issue isn’t evidence of illegality—it’s the appearance of conflict of interest. The problem is, (Trump) bought stock in a company whose business would grow if his administration expanded immigration enforcement.”

Deborah Fleischaker, who served as acting chief of staff at ICE during the Biden administration, also called the timing “troubling,” but noted that public records alone can’t determine if there was misconduct. She now works for the nonprofit Latino civil rights advocacy group UnidosUS. She said:

“It’s not smart—to buy stock in a company affected by your agency’s decisions. I’d steer clear of real wrongdoing, and the appearance of wrongdoing.”

Axon’s federal business expanding rapidly, more than just electroshock weapons

For Axon, with a market cap around $35 billion, the significance of this potential contract goes beyond the hardware. Law enforcement experts note that one-off equipment procurement is often the start of a long-term tech relationship—including cloud storage, evidence management systems, body cameras, real-time operations tools, and AI products.

Axon already holds a $370 million DHS body camera/software contract awarded in 2023—though only about $67.5 million has been appropriated, according to government market intelligence platform HigherGov.

Performance-wise, Axon just posted record revenues: Q4 2025 revenue at $796.7 million, up 39% year-on-year; Q1 2026 revenue $807.3 million, up 34%, powered by electroshock weapon sales and a rapidly expanding AI product line. Executives told investors in February that the DHS contract was a “major opportunity.”

To expand its federal business, Axon has heavily bolstered its team. At a May 6 earnings call, Axon President Joshua Isner said the company had “rebuilt most of” its federal team and recruited Claudia Davidson from Palantir—she worked at Palantir for over seven years, focusing on federal business development.

Isner said federal business was “heading in the right direction,” and “if a few things go well, this will be a banner year for federal business.”

Expansion of surveillance ecosystem raises civil rights concerns

Civil rights advocates are wary of Axon’s broader influence. Axon’s software platform can integrate body cameras, drones, fixed cameras, and other real-time video sources.

Matthew Guariglia, senior policy analyst at the Electronic Frontier Foundation (EFF), focused on law enforcement surveillance, warned that if ICE expands enforcement and closely collaborates with state and local police, these systems could give federal agents a real-time panoramic view of local operations.

“If they can access Ring cameras, livestreams, body cameras, and other local video feeds, this isn’t just about officer safety or accountability anymore,” Guariglia said. “This becomes a platform allowing federal law enforcement to track locations and ground activity in real time at local granularity.”

Axon announced its partnership with Ring in 2025, allowing Ring users to voluntarily share video with law enforcement via Axon’s evidence platform; its Fusus platform aggregates community cameras, body cameras, drones, and other video sources onto a real-time map.

Political maneuvering intensifies, shareholders demand transparency

Axon continues to ramp up lobbying efforts in Washington. Nonprofit OpenSecrets, which tracks political spending, reports that Axon spent nearly $2.5 million on lobbying last year—a record high—with issues ranging from body cameras, anti-drone tech, to digital evidence management legislation and regulation.

Lobbying is showing results. Congress has inserted a $20 million earmark in DHS funding requiring body cameras for immigration enforcement personnel, which experts say is partly due to Axon’s lobbying.

Democratic Senators Ruben Gallego and Mark Kelly also proposed legislation requiring all DHS officers to wear body cameras, but the bill hasn’t gained Republican support, and prospects are limited in the GOP-controlled Senate. OpenSecrets data shows donors linked to Axon contributed more than $20,000 to Gallego during the 2024 election cycle.

At the shareholder level, Axon’s political spending faces pressure. The Nathan Cummings Foundation filed a lawsuit in January seeking to prevent Axon from excluding a shareholder proposal to disclose political spending; the case was settled March 9. Former SEC lawyer Richard Kirby, who represented the foundation, said:

“Since Trump took office, Axon has spent heavily in politics to win contracts and favorable legislation. That’s exactly why investors need transparency.”

Risk Warning and DisclaimerThe market involves risk; invest prudently. This article does not constitute personal investment advice, nor does it take into account the unique investment objectives, financial situation or needs of any individual user. Users should consider whether any opinions, viewpoints or conclusions herein fit their specific situation. Investments made based on this are at your own risk. ```